Val Gebski
Professor
Medicine
University of Sydney
Australia
Biography
Professor Val Gebski is head of biostatistics and research methodology at the NHMRC Clinical Trials Centre which he joined in 1988. He has extensive knowledge of clinical trial methodology, conduct and analysis and is the Group Statistician for a number of national collaborative clinical trials groups in oncology. He has a BA and MStat and is also involved in curriculum development and teaching in the Masters of Public Health, Clinical Epidemiology and Medicine at the University of Sydney. He is the statistical examiner for the Royal Australian and New Zealand College of Radiologists.
Research Interest
Methods for Clinical Trials design Competing risks in studies with time-to-event outcomes • Study designs examining the impact of biomarkers • Novel statistical methods for clinical trials analysis
Publications
-
Janda, M., Gebski, V., Davies, L., Forder, P., Brand, A., Hogg, R., Jobling, T., Land, R., Manolitsas, T., Nascimento, M., et al (2017). Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage i endometrial cancer: A randomized clinical trial. JAMA: The Journal of the American Medical Association, 317(12), 1224-1233
-
Clark, W., Bird, P., DIamond, T., Gonski, P., Barnes, E., Gebski, V. (2017). Criticisms of the VAPOUR trial in a recent commentary are unsubstantiated and incorrect. Evidence-Based Medicine, 22(3), 116-117
-
Lindemann, K., Gibbs, E., Avall-Lundqvist, E., dePont Christensen, R., Woie, K., Kalling, M., Auranen, A., Grenman, S., Hoegberg, T., Rosenberg, P., Gebski, V., et al (2017). Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist). British Journal of Cancer, 116(4), 455-463.
